1
|
Monamele G, Tsafack D, Bilounga C, Njankouo Ripa M, Nsangou Yogne C, Munshili Njifon H, Nkom F, Tamoufe U, Esso L, Koro Koro F, Perraut R, Njouom R. The Detection of Influenza Virus Before and During the COVID-19 Pandemic in Cameroon. Influenza Other Respir Viruses 2024; 18:e13313. [PMID: 38757747 PMCID: PMC11099883 DOI: 10.1111/irv.13313] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Revised: 04/22/2024] [Accepted: 04/23/2024] [Indexed: 05/18/2024] Open
Abstract
BACKGROUND Influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are both respiratory viruses with similar clinical manifestations and modes of transmission. This study describes influenza data before and during the coronavirus disease pandemic (COVID-19) in Cameroon and SARS-CoV-2 data during the pandemic period. METHODS The study ran from 2017 to 2022, and data were divided into two periods: before (2017-2019) and during (2020-2022) the COVID-19 pandemic. Nasopharyngeal samples collected from persons with respiratory illness were tested for influenza using the Centers for Disease Control and Prevention (CDC) typing and subtyping assays. During the COVID-19 pandemic, the respiratory specimens were simultaneously tested for SARS-CoV-2 using the DaAn gene protocol or the Abbott real-time SARS-CoV-2 assay. The WHO average curve method was used to compare influenza virus seasonality before and during the pandemic. RESULTS A total of 6246 samples were tested. Influenza virus detection rates were significantly higher in the pre-pandemic period compared to the pandemic period (30.8% vs. 15.5%; p < 0.001). Meanwhile, the SARS-CoV-2 detection rate was 2.5%. A change in the seasonality of influenza viruses was observed from a bi-annual peak before the pandemic to no clear seasonal pattern during the pandemic. The age groups 2-4 and 5-14 years were significantly associated with higher influenza positivity rates in both pre-pandemic and pandemic periods. For SARS-CoV-2, all age groups above 15 years were the most affected population. CONCLUSION The COVID-19 pandemic had a significant impact on the seasonal influenza by changing the seasonality of the virus and reducing its detection rates.
Collapse
Affiliation(s)
- Gwladys Chavely Monamele
- Virology ServiceCentre Pasteur of CameroonYaoundeCameroon
- Faculty of Health SciencesUniversity of BueaBueaCameroon
| | - Desmon Toutou Tsafack
- Virology ServiceCentre Pasteur of CameroonYaoundeCameroon
- Department of BiochemistryUniversity of DoualaDoualaCameroon
| | - Chanceline Ndongo Bilounga
- Department for the Control of Diseases, Epidemics and Pandemics (DLMEP)Ministry of Public HealthYaoundeCameroon
| | | | | | | | | | | | - Linda Esso
- Department for the Control of Diseases, Epidemics and Pandemics (DLMEP)Ministry of Public HealthYaoundeCameroon
| | | | | | - Richard Njouom
- Virology ServiceCentre Pasteur of CameroonYaoundeCameroon
| |
Collapse
|
2
|
Kang VJW, Huang YS, Chen MC, Chiang PY, Sheng WH, Wang HC, Wang TC, Chang YC. CT findings of 144 in-hospital patients with influenza pneumonia: A retrospective analysis. J Formos Med Assoc 2024; 123:381-389. [PMID: 37640653 DOI: 10.1016/j.jfma.2023.08.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 07/08/2023] [Accepted: 08/17/2023] [Indexed: 08/31/2023] Open
Abstract
BACKGROUND/PURPOSE Patients with influenza infection during their period of admission may have worse computed tomography (CT) manifestation according to the clinical status. This study aimed to evaluate the CT findings of in-hospital patients due to clinically significant influenza pneumonia with correlation of clinical presentations. METHODS In this retrospective, single center case series, 144 patients were included. All in-hospital patients were confirmed influenza infection and underwent CT scan. These patients were divided into three groups according to the clinical status of the most significant management: (1) without endotracheal tube and mechanical ventilator (ETTMV) or extracorporeal membrane oxygenation (ECMO); (2) with ETTMV; (3) with ETTMV and ECMO. Pulmonary opacities were scored according to extent. Spearman rank correlation analysis was used to evaluate the correlation between clinical parameters and CT scores. RESULTS The predominant CT manifestation of influenza infection was mixed ground-glass opacity (GGO) and consolidation with both lung involvement. The CT scores were all reach significant difference among all three groups (8.73 ± 6.29 vs 12.49 ± 6.69 vs 18.94 ± 4.57, p < 0.05). The chest CT score was correlated with age, mortality, and intensive care unit (ICU) days (all p values were less than 0.05). In addition, the CT score was correlated with peak lactate dehydrogenase (LDH) level and peak C-reactive protein (CRP) level (all p values were less than 0.05). Concomitant bacterial infection had higher CT score than primary influenza pneumonia (13.02 ± 7.27 vs 8.95 ± 5.99, p < 0.05). CONCLUSION Thin-section chest CT scores correlated with clinical and laboratory parameters in in-hospital patients with influenza pneumonia.
Collapse
Affiliation(s)
| | - Yu-Sen Huang
- Department of Medical Imaging, National Taiwan University, Taipei, Taiwan.
| | - Mei-Chi Chen
- Department of Medical Imaging, National Taiwan University, Taipei, Taiwan.
| | - Pin-Yi Chiang
- Department of Medical Imaging, National Taiwan University, Taipei, Taiwan.
| | - Wang-Huei Sheng
- Division of Infectious Diseases, Department of Internal Medicine, National Taiwan University, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University College of Medicine, Taiwan.
| | - Hao-Chien Wang
- Department of Internal Medicine, National Taiwan University College of Medicine, Taiwan; Division of Chest Medicine, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
| | - Teh-Chen Wang
- Department Medical Imaging, Taipei City Hospital Yang-Ming Branch, Taipei, Taiwan.
| | - Yeun-Chung Chang
- Department of Medical Imaging, National Taiwan University, Taipei, Taiwan; Department of Radiology, National Taiwan University College of Medicine, Taipei, Taiwan.
| |
Collapse
|
3
|
Rodiah I, Vanella P, Kuhlmann A, Jaeger VK, Harries M, Krause G, Karch A, Bock W, Lange B. Age-specific contribution of contacts to transmission of SARS-CoV-2 in Germany. Eur J Epidemiol 2023; 38:39-58. [PMID: 36593336 PMCID: PMC9807433 DOI: 10.1007/s10654-022-00938-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Accepted: 10/03/2022] [Indexed: 01/04/2023]
Abstract
Current estimates of pandemic SARS-CoV-2 spread in Germany using infectious disease models often do not use age-specific infection parameters and are not always based on age-specific contact matrices of the population. They also do usually not include setting- or pandemic phase-based information from epidemiological studies of reported cases and do not account for age-specific underdetection of reported cases. Here, we report likely pandemic spread using an age-structured model to understand the age- and setting-specific contribution of contacts to transmission during different phases of the COVID-19 pandemic in Germany. We developed a deterministic SEIRS model using a pre-pandemic contact matrix. The model was optimized to fit age-specific SARS-CoV-2 incidences reported by the German National Public Health Institute (Robert Koch Institute), includes information on setting-specific reported cases in schools and integrates age- and pandemic period-specific parameters for underdetection of reported cases deduced from a large population-based seroprevalence studies. Taking age-specific underreporting into account, younger adults and teenagers were identified in the modeling study as relevant contributors to infections during the first three pandemic waves in Germany. For the fifth wave, the Delta to Omicron transition, only age-specific parametrization reproduces the observed relative and absolute increase in pediatric hospitalizations in Germany. Taking into account age-specific underdetection did not change considerably how much contacts in schools contributed to the total burden of infection in the population (up to 12% with open schools under hygiene measures in the third wave). Accounting for the pandemic phase and age-specific underreporting is important to correctly identify those groups of the population in which quarantine, testing, vaccination, and contact-reduction measures are likely to be most effective and efficient. Age-specific parametrization is also highly relevant to generate informative age-specific output for decision makers and resource planers.
Collapse
Affiliation(s)
- Isti Rodiah
- grid.7490.a0000 0001 2238 295XDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, DE-38124 Brunswick, Germany ,grid.452463.2German Centre for Infection Research (DZIF), Inhoffenstr. 7, DE-38124 Brunswick, Germany
| | - Patrizio Vanella
- grid.7490.a0000 0001 2238 295XDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, DE-38124 Brunswick, Germany ,grid.10493.3f0000000121858338Chair of Empirical Methods in Social Science and Demography, University of Rostock, Ulmenstr. 69, DE-18057 Rostock, Germany
| | - Alexander Kuhlmann
- grid.9018.00000 0001 0679 2801Faculty of Medicine, Martin Luther University Halle-Wittenberg, Magdeburgerstr. 8, DE-06112 Halle (Saale), Germany ,grid.452624.3German Center for Lung Research (DZL), Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), Carl-Neuberg-Str. 1, DE-30625 Hannover, Germany
| | - Veronika K. Jaeger
- grid.5949.10000 0001 2172 9288Institute of Epidemiology and Social Medicine, University of Münster, Albert-Schweitzer-Campus 1, DE-48149 Münster, Germany
| | - Manuela Harries
- grid.7490.a0000 0001 2238 295XDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, DE-38124 Brunswick, Germany ,grid.452463.2German Centre for Infection Research (DZIF), Inhoffenstr. 7, DE-38124 Brunswick, Germany
| | - Gerard Krause
- grid.7490.a0000 0001 2238 295XDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, DE-38124 Brunswick, Germany ,grid.452463.2German Centre for Infection Research (DZIF), Inhoffenstr. 7, DE-38124 Brunswick, Germany
| | - Andre Karch
- grid.5949.10000 0001 2172 9288Institute of Epidemiology and Social Medicine, University of Münster, Albert-Schweitzer-Campus 1, DE-48149 Münster, Germany
| | - Wolfgang Bock
- grid.7645.00000 0001 2155 0333Technomathematics Group, Department of Mathematics, TU Kaiserslautern, Gottlieb-Daimler-Straße 48, DE-67663 Kaiserslautern, Germany
| | - Berit Lange
- grid.7490.a0000 0001 2238 295XDepartment of Epidemiology, Helmholtz Centre for Infection Research (HZI), Inhoffenstr. 7, DE-38124 Brunswick, Germany ,grid.452463.2German Centre for Infection Research (DZIF), Inhoffenstr. 7, DE-38124 Brunswick, Germany
| |
Collapse
|
4
|
Richard Q, Alizon S, Choisy M, Sofonea MT, Djidjou-Demasse R. Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic. PLoS Comput Biol 2021; 17:e1008776. [PMID: 33661890 PMCID: PMC7963091 DOI: 10.1371/journal.pcbi.1008776] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2020] [Revised: 03/16/2021] [Accepted: 02/07/2021] [Indexed: 11/19/2022] Open
Abstract
In an epidemic, individuals can widely differ in the way they spread the infection depending on their age or on the number of days they have been infected for. In the absence of pharmaceutical interventions such as a vaccine or treatment, non-pharmaceutical interventions (e.g. physical or social distancing) are essential to mitigate the pandemic. We develop an original approach to identify the optimal age-stratified control strategy to implement as a function of the time since the onset of the epidemic. This is based on a model with a double continuous structure in terms of host age and time since infection. By applying optimal control theory to this model, we identify a solution that minimizes deaths and costs associated with the implementation of the control strategy itself. We also implement this strategy for three countries with contrasted age distributions (Burkina-Faso, France, and Vietnam). Overall, the optimal strategy varies throughout the epidemic, with a more intense control early on, and depending on host age, with a stronger control for the older population, except in the scenario where the cost associated with the control is low. In the latter scenario, we find strong differences across countries because the control extends to the younger population for France and Vietnam 2 to 3 months after the onset of the epidemic, but not for Burkina Faso. Finally, we show that the optimal control strategy strongly outperforms a constant uniform control exerted over the whole population or over its younger fraction. This improved understanding of the effect of age-based control interventions opens new perspectives for the field, especially for age-based contact tracing.
Collapse
Affiliation(s)
| | - Samuel Alizon
- MIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France
| | - Marc Choisy
- MIVEGEC, Univ. Montpellier, IRD, CNRS, Montpellier, France
- Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom
- Oxford University Clinical Research Unit, Ho Chi Minh, Vietnam
| | | | | |
Collapse
|
5
|
Avni T, Babich T, Nir A, Yahav D, Shaked H, Sorek N, Zvi HB, Bishara J, Atamna A. Comparison of clinical outcomes of influenza A and B at the 2017-2018 influenza season: a cohort study. Eur J Clin Microbiol Infect Dis 2020; 39:1109-1114. [PMID: 31989376 PMCID: PMC7095355 DOI: 10.1007/s10096-020-03822-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2019] [Accepted: 01/16/2020] [Indexed: 12/02/2022]
Abstract
Influenza has significant morbidity and mortality. Some experts consider infection with influenza B as milder than that with influenza A. The objective of this study is to evaluate the outcomes of hospitalized patients with laboratory-confirmed influenza A or B in 2017–2018 influenza season. All hospitalized patients between October 2017 and April 2018 with laboratory-confirmed influenza A and B were included. The primary composite outcomes were pneumonia/myocarditis/encephalitis, mechanical ventilation, ICU admission, and 30-day mortality. Secondary outcomes were 30-/90-day mortality, length of hospital stay, and readmission rates. The study included 201 influenza A and 325 influenza B. For the primary composite outcome, no significant difference was demonstrated between influenza A and B. Rates of mortality were similar at 30 and 90 days. Influenza A had higher pneumonia rates and mechanical ventilation. On multivariate analysis, higher Charlson’s score, hypoalbuminemia, and vasopressor use were associated with 30-day mortality, while infection with either influenza A or B was not. Influenza A was associated with higher pneumonia and mechanical ventilation rates. However, influenza B resulted with similar 30-day mortality rate as influenza A.
Collapse
Affiliation(s)
- T Avni
- Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital, 49100, Petah-Tikva, Israel
- Internal Medicine Department E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
| | - T Babich
- Internal Medicine Department E, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
| | - A Nir
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
| | - D Yahav
- Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital, 49100, Petah-Tikva, Israel
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
| | - H Shaked
- Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital, 49100, Petah-Tikva, Israel
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
| | - N Sorek
- Clinical Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel
| | - H Ben Zvi
- Clinical Microbiology Laboratory, Rabin Medical Center, Beilinson Hospital, Petah-Tikva, Israel
| | - J Bishara
- Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital, 49100, Petah-Tikva, Israel
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
| | - A Atamna
- Infectious Disease Unit, Rabin Medical Center, Beilinson Hospital, 49100, Petah-Tikva, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
| |
Collapse
|
6
|
Lina B. Clinique et diagnostic de la grippe saisonnière. Actualités Pharmaceutiques 2019; 58:27-30. [DOI: 10.1016/j.actpha.2019.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
7
|
Federici C, Cavazza M, Costa F, Jommi C. Health care costs of influenza-related episodes in high income countries: A systematic review. PLoS One 2018; 13:e0202787. [PMID: 30192781 PMCID: PMC6128484 DOI: 10.1371/journal.pone.0202787] [Citation(s) in RCA: 31] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2017] [Accepted: 08/09/2018] [Indexed: 11/18/2022] Open
Abstract
Introduction This study systematically reviews costing studies of seasonal influenza-like illness (ILI) in high-income countries. Existing reviews on the economic impact of ILI do not report information on drug consumption and its costs, nor do they provide data on the overall cost per episode. Methods The PRISMA-P checklist was used to design the research protocol. Studies included were cost of illness analysis (COI) and modeling studies that estimated the cost of ILI episodes. Records were searched from January 2000 to December 2016 in electronic bibliographic databases including Medline, Embase, Science Direct, the Cochrane Library, the Centre for Reviews and Disseminations of the University of York, and Google scholar. References from the included studies were hand-searched for completion. Abstract screening, full-text analysis and data extraction were performed by two reviewers independently and discrepancies were resolved by discussion with a third reviewer. A standardized, pre-piloted form was used for data extraction. All costs were converted to 2015 US$ Purchasing Power Parities. Results The literature search identified 5,104 records. After abstract and title screening, 76 studies were analyzed full-text and 27 studies were finally included in the review. Full estimates of the cost per episode range from US$19 in Korea to US$323 in Germany. Particularly, the cost per episode of laboratory confirmed influenza cases was estimated between US$64 and US$73. Inpatient and outpatient services account for the majority of the costs. Differences in the estimates may reflect country-specific characteristics, as well as other study-specific features including study design, identification strategy of ILI cases, study populations and types of costs included in the analysis. Children usually register higher costs, whereas evidence for the elderly is less conclusive. Patients risk-profile, co-morbidities and complications are the other important cost-drivers. None of the papers considered appropriateness in resource use (e.g. abuse of antibiotics). Despite cost of illness studies have ultimately a descriptive role, evidence on (in)appropriateness is useful for policy-makers.
Collapse
Affiliation(s)
- Carlo Federici
- Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Milan, Italy
| | - Marianna Cavazza
- Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Milan, Italy
| | - Francesco Costa
- Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Milan, Italy
| | - Claudio Jommi
- Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Milan, Italy
- Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy
- * E-mail:
| |
Collapse
|
8
|
Lissenden B, Balkrishnan R. Does Risk Adjustment Reduce Vaccination in the Elderly? Evidence From Medicare Advantage. Med Care Res Rev 2018; 77:176-186. [PMID: 29998793 DOI: 10.1177/1077558718785559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
To combat risk selection, it is becoming increasingly common for payments to insurers (and providers) to adjust for patients' chronic conditions. A possible unintended negative consequence is to reduce insurers' (and providers') incentives to prevent chronic conditions. This study examined the effect of Medicare's risk adjustment for payments to Medicare Advantage plans, first introduced in 2004, on pneumonia and influenza vaccination for the elderly. The analysis used the 2000 through 2010 waves of the Medicare Current Beneficiary Survey and a difference-in-differences approach. Presumably by decreasing Medicare Advantage plans' positive influence on vaccination, Medicare's risk adjustment policy was estimated to have reduced pneumonia vaccination rates by 2.9 percentage points (4%, p = .039) and to have possibly reduced influenza vaccination rates by 2.2 percentage points (3%, p = .096). The results clarify an argument against including vaccine-preventable conditions, like pneumonia, in a risk adjustment model.
Collapse
|
9
|
Cho SJ, Plataki M, Mitzel D, Lowry G, Rooney K, Stout-Delgado H. Decreased NLRP3 inflammasome expression in aged lung may contribute to increased susceptibility to secondary Streptococcus pneumoniae infection. Exp Gerontol 2018; 105:40-46. [PMID: 29203400 PMCID: PMC5869149 DOI: 10.1016/j.exger.2017.11.010] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2017] [Revised: 11/17/2017] [Accepted: 11/20/2017] [Indexed: 11/24/2022]
Abstract
Post-viral pneumococcal pneumonia is a leading morbidity and mortality in older patients (≥65years of age). The goal of our current study is to understand the impact of chronological aging on innate immune responses to a secondary, post viral infection with Streptococcus pneumoniae, a causative agent of bacterial pneumonia. Using aged murine models of infection, our findings demonstrate increased morbidity and mortality in aged mice within 48h post-secondary S. pneumoniae infection. Increased susceptibility of aged mice was associated with decreased TLR1, TLR6, and TLR9 mRNA expression and diminished IL1β mRNA expression. Examination of NLRP3 inflammasome expression illustrated decreased NLRP3 mRNA expression and decreased IL1β production in aged lung in response to secondary S. pneumoniae infection.
Collapse
Affiliation(s)
- Soo Jung Cho
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, United States
| | - Maria Plataki
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, United States
| | - Dana Mitzel
- Lovelace Respiratory Research Institute, Albuquerque, NM, United States
| | - Gena Lowry
- Lovelace Respiratory Research Institute, Albuquerque, NM, United States
| | - Kristen Rooney
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, United States
| | - Heather Stout-Delgado
- Department of Medicine, Division of Pulmonary and Critical Care Medicine, Weill Cornell Medicine, New York, NY, United States.
| |
Collapse
|
10
|
Cho SJ, Rooney K, Choi AMK, Stout-Delgado HW. NLRP3 inflammasome activation in aged macrophages is diminished during Streptococcus pneumoniae infection. Am J Physiol Lung Cell Mol Physiol 2018; 314:L372-L387. [PMID: 29097427 PMCID: PMC5900358 DOI: 10.1152/ajplung.00393.2017] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2017] [Revised: 10/17/2017] [Accepted: 10/17/2017] [Indexed: 11/22/2022] Open
Abstract
Pneumococcal infections are the eigth leading cause of death in the United States, and it is estimated that older patients (≥65 yr of age) account for the most serious cases. The goal of our current study is to understand the impact of biological aging on innate immune responses to Streptococcus pneumoniae, a causative agent of bacterial pneumonia. With the use of in vitro and in vivo aged murine models, our findings demonstrate that age-enhanced unfolded protein responses (UPRs) contribute to diminished inflammasome assembly and activation during S. pneumoniae infection. Pretreatment of aged mice with endoplasmic reticulum chaperone and the stress-reducing agent tauroursodeoxycholic acid (TUDCA) decreased mortality in aged hosts that was associated with increased NLRP3 inflammasome activation, improved pathogen clearance, and decreased pneumonitis during infection. Taken together, our data provide new evidence as to why older persons are more susceptible to S. pneumoniae and provide a possible therapeutic target to decrease morbidity and mortality in this population.
Collapse
Affiliation(s)
- Soo Jung Cho
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine , New York, New York
| | - Kristen Rooney
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine , New York, New York
| | - Augustine M K Choi
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine , New York, New York
| | - Heather W Stout-Delgado
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine , New York, New York
| |
Collapse
|
11
|
Hall GC, Davies PTG, Karim MY, Haag MDM, O'Leary C. Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu ® ) among adults in THIN database of electronic UK primary healthcare records. Pharmacoepidemiol Drug Saf 2017; 27:52-58. [PMID: 29152808 DOI: 10.1002/pds.4347] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2017] [Revised: 09/27/2017] [Accepted: 10/09/2017] [Indexed: 11/10/2022]
Abstract
PURPOSE To investigate the safety of trivalent seasonal influenza vaccine (TIVc) (Optaflu® ), the first cell culture seasonal trivalent influenza vaccine available in Europe. METHODS Codes and unstructured text in adult electronic healthcare records (The Health Improvement Network) were searched for a TIVc brand name or batch number and possible outcomes within a 3 month pre- to 6 month post-TIVc exposure study period (2012-2015). The outcomes were severe allergic reactions, Bell's palsy, convulsions, demyelination, paresthesia, noninfectious encephalitis, neuritis (optic and brachial), vasculitis, inflammatory bowel disease, and thrombocytopenia. Risk periods were defined based on biologically plausible time frame postvaccination when an outcome caused by the vaccine might be expected to occur. Possible outcomes were adjudicated against outcome specific case definitions and a date of onset assigned by using electronic and other medical records. Observed (risk period) to expected (outside risk and preexposure periods) rate ratios, postexposure incidence, and plots of time from exposure to outcome were reported. RESULTS Sixteen of 1011 events from 4578 exposures fulfilled a primary case definition and had a date of onset during the study period. Three were in observed time. The observed-to-expected rate ratios were (3.3, 95% CI 0.3, 31.7) for convulsions and (1.5, 95% CI 0.2, 14.9) for thrombocytopenia with 1 outcome each in observed time. There was 1 incident inflammatory bowel disease in observed, but none in expected, time. CONCLUSION The small sample size restricts interpretation; however, no hypothesis of an increased risk of a study outcome was generated. Adjudication of events against case definitions to reduce misclassification of onset and outcomes allowed use of precise risk periods. KEY POINTS This observational study did not generate a hypothesis of an association between the first cell-culture seasonal influenza vaccination available in the European Union and any of the study outcomes (severe allergic reactions, Bell's palsy, convulsions, demyelination, paresthesia, noninfectious encephalitis, neuritis [optic and brachial], vasculitis, inflammatory bowel disease [IBD], and thrombocytopenia). The small sample size limits interpretation of the results. The review of each possible outcome identified from electronic healthcare records against case definitions was included to minimize misclassification of time and outcomes and allow the use of precise risk-periods in an observed-to-expected within cohort analysis. Plots of time from exposure to outcome were included to assess the risk windows.
Collapse
Affiliation(s)
| | | | - M Yousuf Karim
- Frimley Park, Royal Surrey County, St Peter's Hospitals, Surrey, UK
| | | | | |
Collapse
|
12
|
Hong KW, Cheong HJ, Song JY, Noh JY, Yang TU, Kim WJ. Clinical manifestations of influenza A and B in children and adults at a tertiary hospital in Korea during the 2011-2012 season. Jpn J Infect Dis 2014; 68:20-6. [PMID: 25420662 DOI: 10.7883/yoken.jjid.2013.466] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
This study aims to evaluate and compare the epidemiological patterns and clinical courses of influenza A and B among children and adults. For this purpose, we retrospectively reviewed the medical records of 809 children and 271 adolescents/adults with laboratory-confirmed influenza between October 2011 and May 2012 at a tertiary-care hospital. Children with influenza B presented with high fever (body temperature >39℃), sputum production, diarrhea, nausea/vomiting, and myalgia more frequently than those with influenza A. Children with influenza B also showed longer intervals from symptom onset to the initiation of antivirals and higher rates of antibiotic prescription and hospitalization than those with influenza A. Adults aged 20-59 years accounted for approximately 16% and 20% of patients with influenza A and B, respectively. Although clinical manifestations and outcomes were similar between adult patients with influenza A and those with influenza B, influenza B may cause substantial disease burden among not only children but also socially active adults aged 20-59 years.
Collapse
Affiliation(s)
- Kyung-Wook Hong
- Division of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine
| | | | | | | | | | | |
Collapse
|
13
|
Fitchett JR, Arnott ND. Influenza vaccination uptake among people aged over 85 years: an audit of primary care practice in the UK. JRSM Open 2014; 5:2054270414531122. [PMID: 25057409 PMCID: PMC4100234 DOI: 10.1177/2054270414531122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Affiliation(s)
- Joseph R Fitchett
- King’s College London, SE1 9RT, UK
- University College London, NW3 2PF, UK
| | | |
Collapse
|
14
|
Mitzel DN, Lowry V, Shirali AC, Liu Y, Stout-Delgado HW. Age-enhanced endoplasmic reticulum stress contributes to increased Atg9A inhibition of STING-mediated IFN-β production during Streptococcus pneumoniae infection. J Immunol 2014; 192:4273-83. [PMID: 24670807 PMCID: PMC4007355 DOI: 10.4049/jimmunol.1303090] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Pneumococcal infections remain a leading cause of death in persons ≥ 65 y of age. Recent reports have illustrated detrimental changes in the endoplasmic reticulum stress response or unfolded protein response in aging and age-related diseases; however, the relationship between aging, the unfolded protein response, and innate immune responses to Streptococcus pneumoniae has not been fully elucidated. Our results illustrate that stimulator of IFN genes-mediated production of IFN-β during S. pneumoniae infection is decreased in aged hosts. Enhanced endoplasmic reticulum stress in response to S. pneumoniae augmented inositol-requiring protein 1/X-box binding protein 1-mediated production of autophagy-related gene 9 (Atg9a). Knockdown of Atg9a or treatment with gemcitabine HCl resulted in enhanced stimulator of IFN genes-mediated production of IFN-β by aged macrophages. Consecutive treatments with gemcitabine during in vivo S. pneumoniae infection decreased morbidity and mortality in aged hosts, which was associated with decreased Atg9a expression, increased IFN-β production, and improved bacterial clearance from lung tissue. Taken together, data presented in this study provide new evidence as to why older persons are more susceptible to S. pneumoniae, and provide a possible mechanism to enhance these responses, thereby decreasing morbidity and mortality in this population.
Collapse
Affiliation(s)
- Dana N Mitzel
- Animal Biosafety Level 3 Management Support, Lovelace Respiratory Research Institute, Albuquerque, NM 87108
| | | | | | | | | |
Collapse
|
15
|
Abstract
Optimal control strategies for controlling seasonal influenza transmission in the US are of high interest, because of the significant epidemiological and economic burden of influenza. To evaluate optimal strategies of vaccination and social distancing, we used an age-structured dynamic model of seasonal influenza. We applied optimal control theory to identify the best way of reducing morbidity and mortality at a minimal cost. In combination with the Pontryagins maximum principle, we calculated time-dependent optimal policies of vaccination and social distancing to minimize the epidemiological and economic burden associated with seasonal influenza. We computed optimal age-specific intervention strategies and analyze them under various costs of interventions and disease transmissibility. Our results show that combined strategies have a stronger impact on the reduction of the final epidemic size. Our results also suggest that the optimal vaccination can be achieved by allocating most vaccines to preschool-age children (age under five) followed by young adults (age 20-39) and school age children (age 6-19). We find that the optimal vaccination rates for all age groups are highest at the beginning of the outbreak, requiring intense effort at the early phase of an epidemic. On the other hand, optimal social distancing of clinical cases tends to last the entire duration of an outbreak, and its intensity is relatively equal for all age groups. Furthermore, with higher transmissibility of the influenza virus (i.e. higher R0), the optimal control strategy needs to include more efforts to increase vaccination rates rather than efforts to encourage social distancing. Taken together, public health agencies need to consider both the transmissibility of the virus and ways to encourage early vaccination as well as voluntary social distancing of symptomatic cases in order to determine optimal intervention strategies against seasonal influenza.
Collapse
Affiliation(s)
- Eunha Shim
- Department of Mathematics, University of Tulsa, Tulsa, OK 74104, United States.
| |
Collapse
|
16
|
SAYERS G, IGOE D, CARR M, COSGRAVE M, DUFFY M, CROWLEY B, O'HERLIHY B. High morbidity and mortality associated with an outbreak of influenza A(H3N2) in a psycho-geriatric facility. Epidemiol Infect 2013; 141:357-65. [PMID: 22672856 PMCID: PMC9167657 DOI: 10.1017/s0950268812000659] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2011] [Revised: 03/13/2012] [Accepted: 03/21/2012] [Indexed: 11/06/2022] Open
Abstract
In spring 2008, an influenza A subtype H3N2 outbreak occurred in a long stay psycho-geriatric ward and two wards in the intellectual disability services (IDS), part of a large psychiatric hospital. The attack rate in the index ward was 90% (18/20) for patients and 35% (7/20) for staff. It was 14% (1/7) and 17% (2/12) in the affected IDS wards for patients and 0% (0/20) and 4% (1/25) for staff. Many of the laboratory-confirmed cases did not have a fever >38 °C, a typical sign of influenza. Control measures included oseltamivir treatment for cases and prophylaxis for contacts, standard and droplet infection control precautions, active surveillance for early detection and isolation of potential cases. As a result, the outbreak did not spread throughout the hospital. Although the staff vaccination rate (10%) prior to the outbreak was low, we observed a much lower vaccine effectiveness rate in the patients (11%) than in the staff (100%) in the index ward. Vaccination of residents and staff of such facilities remains the key influenza prevention strategy.
Collapse
Affiliation(s)
- G. SAYERS
- Department of Public Health, Health Service Executive, Dublin, Ireland
| | - D. IGOE
- Health Protection Surveillance Centre, Dublin, Ireland
| | - M. CARR
- National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
| | - M. COSGRAVE
- North Dublin Mental Health Service, Health Service Executive, North Dublin, Ireland
| | - M. DUFFY
- National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
| | - B. CROWLEY
- St James's Hospital, Dublin 8 and National Virus Reference Laboratory, University College Dublin, Dublin, Ireland
| | - B. O'HERLIHY
- Department of Public Health, Health Service Executive, Dublin, Ireland
| |
Collapse
|
17
|
Van Vlaenderen I, Van Bellinghen LA, Meier G, Nautrup BP. An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models. BMC Infect Dis 2013; 13:25. [PMID: 23339290 PMCID: PMC3570298 DOI: 10.1186/1471-2334-13-25] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2012] [Accepted: 01/14/2013] [Indexed: 11/10/2022] Open
Abstract
Background Indirect herd effect from vaccination of children offers potential for improving the effectiveness of influenza prevention in the remaining unvaccinated population. Static models used in cost-effectiveness analyses cannot dynamically capture herd effects. The objective of this study was to develop a methodology to allow herd effect associated with vaccinating children against seasonal influenza to be incorporated into static models evaluating the cost-effectiveness of influenza vaccination. Methods Two previously published linear equations for approximation of herd effects in general were compared with the results of a structured literature review undertaken using PubMed searches to identify data on herd effects specific to influenza vaccination. A linear function was fitted to point estimates from the literature using the sum of squared residuals. Results The literature review identified 21 publications on 20 studies for inclusion. Six studies provided data on a mathematical relationship between effective vaccine coverage in subgroups and reduction of influenza infection in a larger unvaccinated population. These supported a linear relationship when effective vaccine coverage in a subgroup population was between 20% and 80%. Three studies evaluating herd effect at a community level, specifically induced by vaccinating children, provided point estimates for fitting linear equations. The fitted linear equation for herd protection in the target population for vaccination (children) was slightly less conservative than a previously published equation for herd effects in general. The fitted linear equation for herd protection in the non-target population was considerably less conservative than the previously published equation. Conclusions This method of approximating herd effect requires simple adjustments to the annual baseline risk of influenza in static models: (1) for the age group targeted by the childhood vaccination strategy (i.e. children); and (2) for other age groups not targeted (e.g. adults and/or elderly). Two approximations provide a linear relationship between effective coverage and reduction in the risk of infection. The first is a conservative approximation, recommended as a base-case for cost-effectiveness evaluations. The second, fitted to data extracted from a structured literature review, provides a less conservative estimate of herd effect, recommended for sensitivity analyses.
Collapse
|
18
|
Towers S, Feng Z. Social contact patterns and control strategies for influenza in the elderly. Math Biosci 2012; 240:241-9. [PMID: 22877728 DOI: 10.1016/j.mbs.2012.07.007] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2011] [Revised: 07/20/2012] [Accepted: 07/21/2012] [Indexed: 10/28/2022]
Abstract
Despite dramatic increases in influenza vaccination coverage in the elderly population over the past 30 years, influenza mortality rates have remained static in this age group. Children are believed to be the primary spreaders of diseases such as influenza due to their high degree of inter-contact in school settings, and several studies have examined control of influenza in the entire population, including the elderly, via targeted vaccination of school children. However, such vaccination programs are expensive, and fraught with difficulties of public perception of what may be seen as an unnecessary vaccination against a disease that is normally mild in the children themselves. In the study presented here, we examine the control of influenza in the elderly using simple social distancing measures during an influenza epidemic. The recent work of Glasser et al. characterizes daily contact interactions within the population in terms of preferential mixing between age group peers, co-workers, and parents and children. We expand upon this to include interactions between grandparents and grandchildren, and fit the parameters of this formulation to the recently published social contact survey data of Mossong et al. Using this formulation, we then model an influenza epidemic with an age-structured deterministic disease model and examine how reduction in contacts between grandchildren and grandparents affects the spread of influenza to the elderly. We find that over 50% of all influenza infections in the elderly are caused by direct contact with an infected child, and we determine that social distancing between grandparents and grandchildren is remarkably effective, and is capable of reducing influenza attack rates in the elderly by up to 60%.
Collapse
Affiliation(s)
- S Towers
- Department of Mathematics, Purdue University, West Lafayette, IN 47907, USA.
| | | |
Collapse
|
19
|
Cappelletti M, Taddeo A, Colombo E, Brambilla L, Bellinvia M, Pregliasco F, Villa ML, Della Bella S. Immunogenicity and safety of seasonal influenza vaccination in patients with classic Kaposi's sarcoma. J Invest Dermatol 2012; 132:2414-2421. [PMID: 22622418 DOI: 10.1038/jid.2012.151] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Classic Kaposi's sarcoma (cKS) is a human herpesvirus-8 (HHV-8)-associated lympho-angioproliferative tumor typically occurring in the elderly. It is associated with HHV-8-driven perturbed balance of peripheral B-cell subsets, which may have an impact on immune responses to antigenic stimulation. We took advantage of the common practice of cKS patients to undergo seasonal influenza vaccination because of advanced age and analyzed the immunogenicity and safety of licensed trivalent influenza vaccine in 46 cKS patients and 44 matched controls. Licensure criteria for immunogenicity were fulfilled in both groups. Four weeks after vaccination, hemagglutination-inhibition antibody titers against each viral strain contained in the vaccine increased in patients and controls (all P<0.001). Protection against at least one strain was achieved by 96% of cKS and 91% of control subjects. Protection against all strains persisted after 12 weeks, demonstrating a long-lasting response to vaccination. The vaccine was equally well tolerated by patients and controls, as assessed by evaluating solicited local and systemic reactions to the vaccine, and appearance or increase of antinuclear autoantibodies. HHV-8 virological rebound was observed in four cKS patients, but was not accompanied by progression of KS lesions. We conclude that seasonal influenza vaccine given to cKS patients is immunogenic and safe.
Collapse
Affiliation(s)
- Monica Cappelletti
- Department of Biomedical Sciences and Technologies, University of Milan, Milano, Italy
| | - Adriano Taddeo
- Department of Biomedical Sciences and Technologies, University of Milan, Milano, Italy
| | - Elena Colombo
- Department of Biomedical Sciences and Technologies, University of Milan, Milano, Italy
| | - Lucia Brambilla
- Institute of Dermatological Sciences, Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milano, Italy
| | - Monica Bellinvia
- Institute of Dermatological Sciences, Fondazione IRCCS Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milano, Italy
| | - Fabrizio Pregliasco
- Department of Public Health, Microbiology and Virology, University of Milan, Milano, Italy
| | - Maria L Villa
- Department of Biomedical Sciences and Technologies, University of Milan, Milano, Italy
| | - Silvia Della Bella
- Department of Translational Medicine, University of Milan, Laboratory of Clinical and Experimental Immunology, IRCCS Istituto Clinico Humanitas, Rozzano (Milano), Italy.
| |
Collapse
|
20
|
Cai S, Feng Z, Fennell ML, Mor V. Despite small improvement, black nursing home residents remain less likely than whites to receive flu vaccine. Health Aff (Millwood) 2012; 30:1939-46. [PMID: 21976338 DOI: 10.1377/hlthaff.2011.0029] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
Vaccination is a key deterrent to influenza and its related complications and outcomes, including hospitalization and death. Using 2006-09 data, we found a small improvement in vaccination rates among nursing home residents, particularly for blacks. Nonetheless, overall vaccination rates remained well below the 90 percent target for high-quality care, and black nursing home residents remained less likely to be vaccinated than whites. Blacks were less likely to be vaccinated than were whites in the same facility and were more likely to live in facilities with lower vaccination rates. Blacks were also more likely to be noted as refusing vaccination. Strategies are needed to ensure that facilities offer vaccination to all residents and to make vaccination more acceptable to black residents and their families.
Collapse
Affiliation(s)
- Shubing Cai
- Center for Gerontology and Health Care Research, Brown University, Providence, Rhode Island, USA.
| | | | | | | |
Collapse
|
21
|
Ryu SY, Kim SH, Park HS, Park J. Influenza vaccination among adults 65 years or older: a 2009-2010 community health survey in the Honam region of Korea. Int J Environ Res Public Health 2011; 8:4197-206. [PMID: 22163202 DOI: 10.3390/ijerph8114197] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 10/17/2011] [Accepted: 11/02/2011] [Indexed: 11/22/2022]
Abstract
The present study examined the rates and related factors for influenza vaccination among the elderly Korean population during the 2008/09 influenza seasons. We obtained data for 6,391 adults aged 65 years or older from Community Health Surveys conducted in 2009 and 2010 in 13 communities in the Honam region of Korea. A multiple logistic regression analysis was used to identify the factors associated with self-reported influenza vaccinations. In this elderly population, 81.7% reported to having received an influenza vaccination in the past year. The main contributing factors were older age, lower economic status, lower educational level, married, non-smoking, regular alcohol consumption, regular walking exercise, receiving a health check-up during the past two years, not stressed, and having comorbid conditions. The influenza vaccination coverage rate among elderly Koreans was relatively high, but improvements in vaccination rates are required.
Collapse
|
22
|
Humiston SG, Bennett NM, Long C, Eberly S, Arvelo L, Stankaitis J, Szilagyi PG. Increasing inner-city adult influenza vaccination rates: a randomized controlled trial. Public Health Rep 2011; 126 Suppl 2:39-47. [PMID: 21812168 DOI: 10.1177/00333549111260s206] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
OBJECTIVES In a population of seniors served by urban primary care centers, we evaluated the effect of the practice-based intervention on influenza immunization rates and disparities in vaccination rates by race/ethnicity and insurance status. METHODS A randomized controlled trial during 2003-2004 tested patient tracking/recall/outreach and provider prompts on improving influenza immunization rates. Patients aged > or = 65 years in six large inner-city primary care practices were randomly allocated to study or control group. Influenza immunization coverage was measured prior to enrollment and on the end date. RESULTS At study end, immunization rates were greater for the intervention group than for the control group (64% vs. 22%, p < 0.0001). When controlling for other factors, the intervention group was more than six times as likely to receive influenza vaccine. The intervention was effective across gender, race/ ethnicity, age, and insurance subgroups. Among the intervention group, 3.5% of African Americans and 3.2% of white people refused influenza immunization. CONCLUSIONS Patient tracking/recall/outreach and provider prompts were intensive but successful approaches to increasing seasonal influenza immunization rates among this group of inner-city seniors.
Collapse
Affiliation(s)
- Sharon G Humiston
- University of Rochester Medical Center, The School of Medicine and Dentistry, Rochester, NY, USA.
| | | | | | | | | | | | | |
Collapse
|
23
|
Tomas J, Lelièvre F, Bercelli P, Glanddier PY, Fanello S, Tuffreau F, Tallec A. Hospital admissions related to influenza in France during the 2006/2007 epidemic. Rev Epidemiol Sante Publique 2011; 59:159-67. [PMID: 21621359 DOI: 10.1016/j.respe.2011.01.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2010] [Revised: 11/29/2010] [Accepted: 01/05/2011] [Indexed: 10/18/2022] Open
Abstract
BACKGROUND The data available on hospital admissions related to influenza mostly concern in-patients admitted via the emergency department. Severe cases have been collated by intensive care practitioners since 2009. For this survey, we searched French hospital admission databases to estimate the prevalence rate of hospital admissions related to influenza and to record qualitative data. METHOD All case studies identified between October 2006 and September 2007 were split into two groups: the first displaying symptoms of clinical influenza and the second suffering from influenza as an associated diagnosis. RESULTS We collected 6797 hospital admissions, 2126 of which were closely related to clinical influenza. Fifty percent of cases concerned the elderly and young people. Fifty-six hospital deaths were recorded in which influenza was the underlying cause in 21% of the cases (12). When influenza was an associated diagnosis (44/56), cardiovascular or respiratory diseases were the main causes (26/44). CONCLUSION During the same period (2006-2007), the French Sentinel Surveillance identified only 105 hospital admissions related to influenza. Our survey was therefore more exhaustive and was able to record qualitative data. Inclusion of hospital admissions with an associated diagnosis of influenza is debatable because this decreases specificity. The relationship between the principal diagnosis and all the associated diagnoses is difficult to study, although exclusion of this type of hospitalization could significantly underestimate these figures. Despite certain limitations, French hospital admissions databases should complement French Sentinel Surveillance data.
Collapse
Affiliation(s)
- J Tomas
- Observatoire Régional de la Santé (ORS) Pays de la Loire, Hôtel de la Région, 1 Rue de la Loire, 44966 Nantes Cedex 9, France.
| | | | | | | | | | | | | |
Collapse
|
24
|
Irving SA, Patel DC, Kieke BA, Donahue JG, Vandermause MF, Shay DK, Belongia EA. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004-2005 through 2007-2008. Influenza Other Respir Viruses 2011; 6:37-43. [PMID: 21668663 PMCID: PMC4941556 DOI: 10.1111/j.1750-2659.2011.00263.x] [Citation(s) in RCA: 86] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Please cite this paper as: Irving et al. (2012) Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008. Influenza and Other Respiratory Viruses 6(1), 37–43. Background There are few prospectively collected data comparing illnesses caused by different subtypes of influenza. We compared the clinical presentation and outcomes of subjects with primarily outpatient‐attended influenza A and B infections during four consecutive influenza seasons (2004–2005 through 2007–2008). Methods Patients were prospectively enrolled and tested for influenza following an encounter for acute respiratory illness. Influenza infections were confirmed by culture or reverse transcription polymerase chain reaction; subtype was determined for a sample of influenza A isolates each season. Clinical characteristics of influenza A and B infections were compared across and within individual seasons. Results We identified 901 cases of influenza A and 284 cases of influenza B; 98% of cases were identified through an outpatient medical encounter. Thirty‐six percent of patients with each strain had received seasonal influenza vaccine prior to illness onset. There were no consistent differences in symptoms associated with influenza A and B. Influenza A infection was associated with earlier care seeking compared with influenza B during the 2005–2006 and 2007–2008 seasons, when H3N2 was the dominant type A virus, and in a combined analysis that included all seasons. Twenty‐six (2·2%) of 1185 cases were diagnosed with radiographically confirmed pneumonia, and 59 (5%) of 1185 patients were hospitalized within 30 days of illness onset. Conclusions Over four influenza seasons, aside from shorter intervals from illness onset to clinical encounter for infections with the A(H3N2) subtype, clinical symptoms and outcomes were similar for patients with predominantly outpatient‐attended influenza A and B infections.
Collapse
|
25
|
Chan EH, Tamblyn R, Charland KM, Buckeridge DL. Outpatient physician billing data for age and setting specific syndromic surveillance of influenza-like illnesses. J Biomed Inform 2011; 44:221-8. [DOI: 10.1016/j.jbi.2010.10.001] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2010] [Revised: 09/18/2010] [Accepted: 10/11/2010] [Indexed: 11/21/2022]
|
26
|
Baxter R, Ray GT, Fireman BH. Effect of influenza vaccination on hospitalizations in persons aged 50 years and older. Vaccine 2010; 28:7267-72. [DOI: 10.1016/j.vaccine.2010.08.088] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2010] [Revised: 08/13/2010] [Accepted: 08/24/2010] [Indexed: 11/21/2022]
|
27
|
Jackson ML. Confounding by season in ecologic studies of seasonal exposures and outcomes: examples from estimates of mortality due to influenza. Ann Epidemiol 2009; 19:681-91. [PMID: 19700344 DOI: 10.1016/j.annepidem.2009.06.009] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2009] [Revised: 06/09/2009] [Accepted: 06/25/2009] [Indexed: 11/27/2022]
Abstract
PURPOSE Many health outcomes exhibit seasonal variation in incidence, including accidents, suicides, and infections. For seasonal outcomes it can be difficult to distinguish the causal roles played by factors that also vary seasonally, such as weather, air pollution, and pathogen circulation. METHODS Various approaches to estimating the association between a seasonal exposure and a seasonal outcome in ecologic studies are reviewed, using studies of influenza-related mortality as an example. Because mortality rates vary seasonally and circulation of other respiratory viruses peaks during influenza season, it is a challenge to estimate which winter deaths were caused by influenza. Results of studies that estimated the contribution of influenza to all-cause mortality using different methods on the same data are compared. RESULTS Methods for estimating associations between season exposures and outcomes vary greatly in their advantages, disadvantages, and assumptions. Even when applied to identical data, different methods can give greatly different results for the expected contribution of influenza to all-cause mortality. CONCLUSIONS When the association between exposures and outcomes that vary seasonally is estimated, models must be selected carefully, keeping in mind the assumptions inherent in each model.
Collapse
Affiliation(s)
- Michael L Jackson
- Group Health Center for Health Studies, Seattle, WA 98101-1448, USA.
| |
Collapse
|
28
|
Talbird SE, Brogan AJ, Winiarski AP, Sander B. Cost-effectiveness of treating influenzalike illness with oseltamivir in the United States. Am J Health Syst Pharm 2009; 66:469-80. [PMID: 19233995 DOI: 10.2146/ajhp080296] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
PURPOSE The cost-effectiveness of treating influenzalike illness (ILI) with oseltamivir in the United States was assessed. METHODS A decision-analysis model was developed with a one-year time horizon to assess the cost-effectiveness of oseltamivir compared with usual care from societal and payer perspectives for four patient populations: high-risk adults, healthy adults, elderly adults, and children. The model used efficacy data from oseltamivir clinical trials and other published literature and assumed oseltamivir was effective only in individuals infected with influenza virus not resistant to oseltamivir and treated within 48 hours of symptom onset. Direct medical costs were based on resources used; indirect costs were estimated based on time lost from work due to illness and premature mortality. Base-case estimates were tested in one-way sensitivity and variability analyses. RESULTS From a societal perspective, oseltamivir was cost-effective across all populations modeled, with an incremental cost per quality-adjusted life-year gained of $5,388, $6,317, $7,652, and $16,176 for high-risk adults, children, elderly adults, and healthy adults, respectively. Results were similar from a payer perspective. When indirect costs were included (for all populations except elderly adults), oseltamivir was cost saving. In sensitivity analyses, oseltamivir remained cost-effective across all patient populations for all values tested, except the probability of developing influenza-related pneumonia. Variability analyses showed that oseltamivir remained cost-effective under most scenarios tested. CONCLUSION Base-case results and sensitivity analyses from a decision-analysis model found that treatment of ILI with oseltamivir was cost-effective compared with usual care from U.S. payer and societal perspectives in all patient populations studied when only direct costs were considered.
Collapse
Affiliation(s)
- Sandra E Talbird
- RTI Health Solutions, Research Triangle Park, NC 27709-2194, USA.
| | | | | | | |
Collapse
|
29
|
Abstract
Rapid and reliable diagnosis of influenza is essential for identification of contagious patients and effective patient management. Near‐patient assays allow establishment of the diagnosis within minutes in young children, and this study aimed to evaluate near‐patient assays in relation to the patient’s age. A total of 194 patients with laboratory‐confirmed influenza A/H3N2 virus infection, diagnosed within a prospective cohort study, were included. Cryopreserved nasopharyngeal swabs collected from these patients were tested by four near‐patient assays (Binax Now Influenza A&B, Quick S‐Influ A/B, Influ‐A&B Respi‐Strip, and Actim Influenza A&B). The main outcome measure was sensitivity of the near‐patient assays in relation to the age of patients. The Binax Now, Quick S‐Influ, Influ‐A&B Respi‐Strip and Actim assays had overall sensitivities of 19%, 18%, 26%, and 40%, respectively. The estimated sensitivity for influenza A/H3N2 virus detection in nasopharyngeal swabs was 17–56% in children 1 year of age and decreased to 8–22% in patients 80 years of age (logistic regression). The sensitivity of the Influ‐A&B Respi‐Strip and Actim assays decreased significantly with increasing age (p 0.014 and p 0.033, respectively (logistic regression)), a trend for decrease was observed for the Binax Now assay (p 0.074 (logistic regression)), and the low sensitivity of the Quick S‐Influ assay was similar in children and adults. Less than one‐fourth of diagnosed influenza A/H3N2 virus infections can be identified in elderly patients using a near‐patient assay. Consequently, near‐patient assays are of limited value for confirming the diagnosis when influenza is clinically suspected in adults. Antiviral therapy and additional diagnostic procedures cannot be withheld on the basis of a negative near‐patient assay result, particularly in adult patients.
Collapse
Affiliation(s)
- C Steininger
- Department of Internal Medicine, Medical University of Vienna, Vienna, Austria
| | | | | | | | | |
Collapse
|
30
|
Abstract
Influenza vaccination of health care workers (HCW) is widely recommended, but immunization rates are low. In order to assess performance among primary HCW and identify barriers, we conducted a survey among the staff of 27 primary care community clinics in Jerusalem. The low rate of vaccination (30.2%) was in contrast with the large proportion of HCW who considered it desirable to immunize primary health clinic staff (72.1%). Physicians reported having been immunized significantly more (p=0.008) than the rest of the staff. They also had better knowledge and more favorable attitude towards immunization. Also associated (independently of profession) with performance of immunization were age (p<0.001), knowledge (that immunization can not cause influenza, p=0.051), attitude (the belief that it is desirable to immunize primary HCW, p<0.001), previous years' performance of immunization (p<0.001) and a physician's recommendation (p=0.042). A media scare which occurred during the vaccination period was reported to have influenced the decision not to get immunized of 34.1% of HCW who had not been immunized. The study results raise hope of prospective increase in vaccination through educational and technical interventions and by increasing physician involvement.
Collapse
Affiliation(s)
- Zvi Howard Abramson
- Beit Hakerem Community Health Clinic, Clalit Health Services, Haarazim 2, Jerusalem, Israel.
| | | |
Collapse
|
31
|
Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, Smedley J, Murad S, Watson JM. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 2006; 333:1241. [PMID: 17142257 PMCID: PMC1702427 DOI: 10.1136/bmj.39010.581354.55] [Citation(s) in RCA: 291] [Impact Index Per Article: 16.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 10/10/2006] [Indexed: 11/04/2022]
Abstract
OBJECTIVE To determine whether vaccination of care home staff against influenza indirectly protects residents. DESIGN Pair matched cluster randomised controlled trial. SETTING Large private chain of UK care homes during the winters of 2003-4 and 2004-5. PARTICIPANTS Nursing home staff (n=1703) and residents (n=2604) in 44 care homes (22 intervention homes and 22 matched control homes). INTERVENTIONS Vaccination offered to staff in intervention homes but not in control homes. MAIN OUTCOME MEASURES The primary outcome was all cause mortality of residents. Secondary outcomes were influenza-like illness and health service use in residents. RESULTS In 2003-4 vaccine coverage in full time staff was 48.2% (407/884) in intervention homes and 5.9% (51/859) in control homes. In 2004-5 uptake rates were 43.2% (365/844) and 3.5% (28/800). National influenza rates were substantially below average in 2004-5. In the 2003-4 period of influenza activity significant decreases were found in mortality of residents in intervention homes compared with control homes (rate difference -5.0 per 100 residents, 95% confidence interval -7.0 to -2.0) and in influenza-like illness (P=0.004), consultations with general practitioners for influenza-like illness (P=0.008), and admissions to hospital with influenza-like illness (P=0.009). No significant differences were found in 2004-5 or during periods of no influenza activity in 2003-4. CONCLUSIONS Vaccinating care home staff against influenza can prevent deaths, health service use, and influenza-like illness in residents during periods of moderate influenza activity. TRIAL REGISTRATION National Research Register N0530147256.
Collapse
Affiliation(s)
- Andrew C Hayward
- University College London Centre for Infectious Disease Epidemiology, Department of Primary Care and Population Sciences, London NW3 2PF.
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
Annual influenza epidemics create a significant public health burden each year in the United States. That influenza continues to pose a public health threat despite being largely preventable through vaccination is indicative of continuing weaknesses in the U.S.'s public health system. Moreover, the burden of annual influenza epidemics and the fragility and instability of the capacity to respond to them underscore the U.S.'s ongoing vulnerability to pandemic influenza and highlights gaps in bioterrorism preparedness and response efforts. This article examines the burden of annual influenza epidemics in the U.S., efforts to combat that burden with vaccination, shortcomings of influenza vaccination efforts, and how those shortcomings exemplify weaknesses in pandemic influenza and bioterrorism preparedness efforts. We make the case for establishing an annual universal influenza vaccination program to assure access to influenza vaccination to anyone who can safely receive vaccination and desires it. Such a program could greatly reduce the annual burden of influenza while advancing and maintaining U.S. pandemic influenza and bioterrorism preparedness and response efforts.
Collapse
Affiliation(s)
- Michael Mair
- Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA.
| | | | | | | |
Collapse
|
33
|
Wong CM, Yang L, Chan KP, Leung GM, Chan KH, Guan Y, Lam TH, Hedley AJ, Peiris JSM. Influenza-associated hospitalization in a subtropical city. PLoS Med 2006; 3:e121. [PMID: 16515368 PMCID: PMC1391978 DOI: 10.1371/journal.pmed.0030121] [Citation(s) in RCA: 120] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/14/2005] [Accepted: 12/21/2005] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND The impact of influenza on morbidity and hospitalization in the tropics and subtropics is poorly quantified. Uniquely, the Hong Kong Special Administrative Region has computerized hospital discharge diagnoses on 95% of total bed days, allowing disease burden for a well-defined population to be accurately assessed. METHODS AND FINDINGS Influenza-associated morbidity and hospitalization was assessed by Poisson regression models for weekly counts of hospitalizations in Hong Kong during 1996 to 2000, using proportions of positive influenza types A (H1N1 and H3N2) and B isolations in specimens sent for laboratory diagnosis as measures of influenza virus circulation. We adjusted for annual trend, seasonality, temperature, and relative humidity, as well as respiratory syncytial virus circulation. We found that influenza was significantly associated with hospitalization for acute respiratory disease (International Classification of Diseases version 9 codes [ICD9] 460-466 and 480-487) and its subcategory pneumonia and influenza (ICD9 480-487) for all age groups. The annual rates of excess hospitalization per 100,000 population for acute respiratory diseases for the age groups 0-14, 15-39, 40-64, 65-74, and 75+ were 163.3 (95% confidence interval [CI], 135-190), 6.0 (95% CI, 2.7-8.9), 14.9 (95% CI, 10.7-18.8), 83.8 (95% CI, 61.2-104.2), and 266 (95% CI, 198.7-330.2), respectively. Influenza was also associated with hospitalization for cerebrovascular disease (ICD9 430-438) for those aged over 75 y (55.4; 95% CI, 23.1-87.8); ischemic heart disease (ICD9 410-414) for the age group 40-64 y (5.3; 95% CI, 0.5-9.5) and over 75 y (56.4; 95% CI, 21.1-93.4); and diabetes mellitus (ICD9 250) for all age groups older than 40 y. CONCLUSIONS Influenza has a major impact on hospitalization due to cardio-respiratory diseases as well as on cerebrovascular disease, ischemic heart disease, and diabetes mellitus in the tropics and subtropics. Better utilization of influenza vaccine during annual epidemics in the tropics will enhance global vaccine production capacity and allow for better preparedness to meet the surge in demand that is inevitable in confronting a pandemic.
Collapse
Affiliation(s)
- Chit Ming Wong
- 1University of Hong Kong, Department of Community Medicine, Hong Kong, Hong Kong Special Administrative Region, China
| | - Lin Yang
- 1University of Hong Kong, Department of Community Medicine, Hong Kong, Hong Kong Special Administrative Region, China
| | - King Pan Chan
- 1University of Hong Kong, Department of Community Medicine, Hong Kong, Hong Kong Special Administrative Region, China
| | - Gabriel M Leung
- 1University of Hong Kong, Department of Community Medicine, Hong Kong, Hong Kong Special Administrative Region, China
| | - Kwok H Chan
- 2University of Hong Kong, Department of Microbiology, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China
| | - Yi Guan
- 2University of Hong Kong, Department of Microbiology, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China
| | - Tai Hing Lam
- 1University of Hong Kong, Department of Community Medicine, Hong Kong, Hong Kong Special Administrative Region, China
| | - Anthony Johnson Hedley
- 1University of Hong Kong, Department of Community Medicine, Hong Kong, Hong Kong Special Administrative Region, China
| | - Joseph S. M Peiris
- 2University of Hong Kong, Department of Microbiology, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China
- * To whom correspondence should be addressed. E-mail:
| |
Collapse
|
34
|
Mair M, Grow RW, Mair JS, Radonovich LJ. Universal Influenza Vaccination: The Time to Act Is Now. Biosecur Bioterror 2006. [DOI: 10.1089/bsp.2006.4.ft-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
35
|
Abstract
From 1987-99, influenza and pneumococcal vaccination rates among elderly Medicare beneficiaries increased by 300 percent and 500 percent, respectively. Despite these gains, annual rates of hospitalizations for pneumonia and influenza (P&I) have not decreased; rather, they have increased steadily. The authors investigate whether this paradoxical increase in hospitalization rates reflects an increasing burden of P&I or the effects of a changing healthcare environment. They find that from 1987-99, P&I hospitalizations per one thousand beneficiaries increased from 15.1 to 23.4. Of this increase, 23 percent was due to an aging Medicare population, 2.4 percent was due to increased rates of rehospitalization, and at most 5 percent was due to upcoding. There was no evidence that physicians were increasingly admitting patients with less complicated cases of P&I. The changing healthcare environment only partially explained the paradoxical increase in P&I hospitalizations. P&I appears to be an increasing burden to the elderly, despite increased vaccination rates.
Collapse
|
36
|
Abstract
Influenza is a serious illness and probably the single most important cause of excess disability and mortality during the winter months. In spite of limited efficacy in older adults, influenza vaccination is nevertheless a cost-saving medical intervention since it does reduce hospitalisation and death rates due to pneumonia, exacerbations of heart failure and, surprisingly, heart attacks and strokes. Yet hospitalisation and death rates for acute respiratory illnesses continue to rise in spite of widespread vaccination programs. As a person ages, the immune response to antigenic stimulation with the influenza virus shifts toward T helper type 2 cytokine production. This is associated with a relative reduction in cytotoxic T-cell activity and a reduced capacity to destroy infected host cells and clear the virus from infected lung tissue. Breakthrough strategies to improve the current influenza vaccines are required to avoid a crisis in health care. A targeted approach will develop vaccines that can reverse these age-related changes in T-cell responses, particularly the functions of cytotoxic T lymphocytes.
Collapse
Affiliation(s)
- Janet E McElhaney
- Center for Immunotherapy of Cancer and Infectious Diseases and UConn Center on Aging, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USA.
| |
Collapse
|
37
|
Abstract
Current available influenza vaccines are safe and effective in preventing influenza. Nevertheless, there is a need for influenza vaccines with improved efficacy in the elderly. This need is underscored by both the observation that influenza has a major clinical and economic impact in the elderly and the fact that currently available vaccines are generally less effective in elderly than in younger subjects. Several approaches are currently being pursued in order to improve the efficacy of influenza vaccines in elderly individuals and others who have impaired immune responses to conventional influenza vaccines. A novel antigen-presenting strategy to overcome impaired immune responses is the use of virosomes. Previously, data on safety and reactogenicity have been published regarding the use of virosomal influenza vaccines. Data from three recent clinical trials are presented here. The first of these was a comparative study of a virosomal vaccine and a conventional subunit vaccine in "at-risk" adults with underlying chronic illness. The virosomal vaccine demonstrated comparable tolerability to the subunit vaccine, with about 98% of patients reporting tolerability to be good or very good. The vast majority of adverse events reported were mild to moderate in severity. With both vaccine types, mean HI titres decreased with age for both the A-H1N1 and B influenza virus strains, but for the A-H3N2 strain (the most virulent of the three strains), mean HI titres did not decrease with age, suggesting a better response with the virosomal vaccine when compared to the subunit vaccine. All three studies explored the long-term persistence of antibodies after vaccination with virosomal influenza vaccines. Immunogenicity declined over time but remained high at 4, 6 and 12 months post-vaccination compared to baseline, indicating that adequate seroprotection is achievable for the duration of the influenza season. Virosomal vaccines may induce better immunity in elderly subjects and may be more effective in reducing morbidity and mortality in this age group.
Collapse
Affiliation(s)
- I A de Bruijn
- Clinical Development Influenza Vaccines, Solvay Pharmaceuticals BV, PO Box 900, 1380 DA, Weesp, The Netherlands.
| | | | | | | | | |
Collapse
|
38
|
Abstract
Influenza causes substantial morbidity across the age spectrum. However, the elderly are especially vulnerable to the serious complications of influenza that might result in hospitalisation or death, and high rates of influenza-associated excess hospitalisation or death that exceed by several-fold the rates seen among most other age groups have consistently been observed in many countries and across many seasons. Thus, the elderly are included among the high priority groups for routine influenza vaccination by many national health authorities. Inactivated influenza virus vaccines are widely available across the globe and are safe and effective. Vaccination of elderly persons has been associated with significant reductions in hospitalisations for pneumonia and influenza as well as hospitalisations for other cardiopulmonary disorders and even cerebrovascular disease. Vaccination has also been associated with reductions in influenza-associated and all-cause mortality during influenza seasons. The benefits of vaccination extend not only to community-dwelling elderly but also to elderly who reside in nursing homes. Likewise, vaccination provides benefits to the very old and to elderly persons with underlying co-morbidities as well as to the healthy elderly. Despite the substantially increased risk for serious complications and impressive benefits from vaccination among the elderly, influenza vaccine utilisation remains below target rates for this group in nearly all countries. The need for improved prevention and control of influenza is recognised as a priority for the global community--both to reduce the morbidity and mortality associated with epidemic influenza and to prepare for the next pandemic. Enhancing vaccine delivery to elderly persons would represent important progress toward that goal.
Collapse
Affiliation(s)
- Kristin L Nichol
- Minneapolis Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota 55417, USA.
| |
Collapse
|